aloxi Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Aloxi, and when can generic versions of Aloxi launch?
Aloxi is a drug marketed by Helsinn Hlthcare and is included in two NDAs. There are thirteen patents protecting this drug and one Paragraph IV challenge.
This drug has fifty-three patent family members in forty countries.
The generic ingredient in ALOXI is palonosetron hydrochloride. There are twenty-one drug master file entries for this compound. Nineteen suppliers are listed for this compound. Additional details are available on the palonosetron hydrochloride profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Aloxi
A generic version of aloxi was approved as palonosetron hydrochloride by SANDOZ on October 13th, 2015.
Summary for aloxi
International Patents: | 53 |
US Patents: | 13 |
Applicants: | 1 |
NDAs: | 2 |
Finished Product Suppliers / Packagers: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 156 |
Patent Applications: | 4,101 |
Formulation / Manufacturing: | see details |
Drug Prices: | Drug price information for aloxi |
Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for aloxi |
What excipients (inactive ingredients) are in aloxi? | aloxi excipients list |
DailyMed Link: | aloxi at DailyMed |
Anatomical Therapeutic Chemical (ATC) Classes for aloxi
Paragraph IV (Patent) Challenges for ALOXI
Tradename | Dosage | Ingredient | Strength | NDA | ANDAs Submitted | Submissiondate |
---|---|---|---|---|---|---|
ALOXI | Injection | palonosetron hydrochloride | 0.05 mg/mL, 1.5 mL and 5 mL vials | 021372 | 3 | 2011-05-27 |
US Patents and Regulatory Information for aloxi
aloxi is protected by seven US patents.
Patents protecting aloxi
Liquid pharmaceutical formulations of palonosetron
Patent Number: ⤷ Try a Trial
Patent Expiration: ⤷ Try a Trial
Liquid pharmaceutical formulations of palonosetron
Patent Number: ⤷ Try a Trial
Patent Expiration: ⤷ Try a Trial
Liquid pharmaceutical formulations of palonosetron
Patent Number: ⤷ Try a Trial
Patent Expiration: ⤷ Try a Trial
Liquid pharmaceutical formulations of palonosetron
Patent Number: ⤷ Try a Trial
Patent Expiration: ⤷ Try a Trial
Liquid pharmaceutical formulations of palonosetron
Patent Number: ⤷ Try a Trial
Patent Expiration: ⤷ Try a Trial
Liquid pharmaceutical formulations of palonosetron
Patent Number: ⤷ Try a Trial
Patent Expiration: ⤷ Try a Trial
Liquid pharmaceutical formulations of palonosetron
Patent Number: ⤷ Try a Trial
Patent Expiration: ⤷ Try a Trial
Expired US Patents for aloxi
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Helsinn Hlthcare | ALOXI | palonosetron hydrochloride | INJECTABLE;INTRAVENOUS | 021372-002 | Feb 29, 2008 | ⤷ Try a Trial | ⤷ Try a Trial |
Helsinn Hlthcare | ALOXI | palonosetron hydrochloride | CAPSULE;ORAL | 022233-001 | Aug 22, 2008 | ⤷ Try a Trial | ⤷ Try a Trial |
Helsinn Hlthcare | ALOXI | palonosetron hydrochloride | INJECTABLE;INTRAVENOUS | 021372-001 | Jul 25, 2003 | ⤷ Try a Trial | ⤷ Try a Trial |
Helsinn Hlthcare | ALOXI | palonosetron hydrochloride | INJECTABLE;INTRAVENOUS | 021372-002 | Feb 29, 2008 | ⤷ Try a Trial | ⤷ Try a Trial |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for aloxi
See the table below for patents covering aloxi around the world.
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
Luxembourg | 91162 | ⤷ Try a Trial | |
Tunisia | SN05180 | LIQUID PHARMACEUTICAL FORMULATIONS OF PALONOSETRON | ⤷ Try a Trial |
Poland | 166277 | ⤷ Try a Trial | |
Australia | 6696390 | ⤷ Try a Trial | |
China | 102813621 | Liquid pharmaceutical formulations of palonosetron | ⤷ Try a Trial |
Norway | 2005023 | ⤷ Try a Trial | |
>Country | >Patent Number | >Title | >Estimated Expiration |
Supplementary Protection Certificates for aloxi
Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
---|---|---|---|---|
0430190 | 300194 | Netherlands | ⤷ Try a Trial | 300194, 20101127, EXPIRES: 20151126 |
1035115 | 92745 | Luxembourg | ⤷ Try a Trial | PRODUCT NAME: NETUPITANT/PALONOSETRON ET LEURS DERIVES PHARMACEUTIQUEMENT ACCEPTABLES (AKYNZEO); FIRST REGISTRATION: 20150527 |
0430190 | 91162 | Luxembourg | ⤷ Try a Trial | 91162, EXPIRES: 20151127 |
2785706 | LUC00158 | Luxembourg | ⤷ Try a Trial | PRODUCT NAME: AKYNZEO - FOSNETUPITANT/PALONOSETRON; AUTHORISATION NUMBER AND DATE: EU/1/15/1001 20200318 |
2785706 | 122020000046 | Germany | ⤷ Try a Trial | PRODUCT NAME: FOSNETUPITANT MIT PALONOSETRON; REGISTRATION NO/DATE: C(2020)1804(FINAL) 20200316 |
0430190 | SPC/GB05/032 | United Kingdom | ⤷ Try a Trial | PRODUCT NAME: PALONOSETRON OR AN ISOMER, MIXTURE OF ISOMERS, N-OXIDE OR PHARMACEUTICALLY ACCEPTABLE SALT THEREOF; REGISTERED: UK EU/1/04/306/001 20050322 |
>Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |